Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
The Potential of the Inhibitors of the Transcriptional Enhanced Associate Domain Protein Factors (TEAD) as a Treatment for Cancer. [PDF]
Abdel-Magid AF.
europepmc +1 more source
SPG4 and Dementia: Expanding the Clinical Spectrum
ABSTRACT Objective Hereditary spastic paraplegia (HSP) is a group of disorders characterized by progressive spasticity and lower limb weakness, with mutations in SPG4/SPAST being the most common cause. Detailed studies and clinical and molecular comparisons across different populations are missing.
Emanuele Panza +19 more
wiley +1 more source
Comparing Large Language Models and Traditional Machine Translation Tools for Translating Medical Consultation Summaries: Quantitative Pilot Feasibility Study. [PDF]
Li A, Zhou W, Hoda R, Bain C, Poon P.
europepmc +1 more source
HealthContradict: Evaluating biomedical knowledge conflicts in language models. [PDF]
Zhang B +4 more
europepmc +1 more source
Enhancing Medical Diagnosis Document Analysis with Layout-Aware Multitask Models. [PDF]
Tu HJ, Hsu JL.
europepmc +1 more source
Developing an Integrated Municipal Environmental Health Framework for Communicable Disease Surveillance and Prevention in South Africa: A Mixed-Methods Study Protocol. [PDF]
Malebana LF, Sepadi MM, Mokgobu MI.
europepmc +1 more source
Eye movement and reading behavior in older adults with dementia. [PDF]
Inuyama A, Ouchi M, Hirano S, Suwa S.
europepmc +1 more source

